InvestorsHub Logo
Followers 23
Posts 3334
Boards Moderated 3
Alias Born 02/16/2017

Re: None

Friday, 04/07/2017 6:13:49 PM

Friday, April 07, 2017 6:13:49 PM

Post# of 106837
Here is some solid DD to think about.

The FDA, RMAT or RAT does not need to be reported by any company. Whether or not it gets approved or rejected. USRM does not have to report it. It's a company's due diligence to keep investors informed of new changes in revenue or new changes in finances. It's a responsibility to inform investors of news.

So, do not be surprised if we do not hear anything from them for quite some time on any approval or rejection news. Revel in the fact that it could happen any day, but do not expect it to happen any time soon.

Sure we can put the pressure on, but what does that really accomplish. USRM has been very quiet regarding any news with FDA. Just a little tidbit of "We are working with them towards approval"

Don't get me wrong here. I am a long holder. I think they will find the exact right time to release this information so that they can and the investors can benefit the most on the release of the news. I think they are stepping up to prepare for a mega increase to revenues or potential buyout with their life changing product. That day will be the day we all can literally take a sigh of relief.

GLTA. I am xxsing my fingers for solid news next week, but I will not be surprised if it doesn't happen.